Cargando…
Drive-Through Model for Anticoagulation Clinics During the COVID-19 Pandemic
The coronavirus disease of 2019 (COVID-19) has posed a major challenge for providers and patients. A large number of patients with atrial fibrillation, venous thromboembolism, or valvular heart disease are chronically anticoagulated with vitamin K antagonists and rely on frequent follow ups at antic...
Autores principales: | Rezaei Bookani, Kaveh, Minga, Iva, Chander, Manisha, Hankewych, Ksenia, Plassmeier, Matthew, Tafur, Alfonso |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444151/ https://www.ncbi.nlm.nih.gov/pubmed/32822220 http://dx.doi.org/10.1177/1076029620947476 |
Ejemplares similares
-
Evidence-Based Practical Guidance for the Antithrombotic Management in Patients With Coronavirus Disease (COVID-19) in 2020
por: Ramacciotti, Eduardo, et al.
Publicado: (2020) -
The Efficacy and Safety of Prolonged Oral Anticoagulation for the
Prevention of Thromboembolic Events in Patients Recovered From COVID-19 1 Year
After Hospital Discharge: The SARCOV-19 Prospective Registry
por: Aidouni, Ghizlane El, et al.
Publicado: (2023) -
COVID-19 May Predispose to Thrombosis by Affecting Both Vascular Endothelium and Platelets
por: Cure, Erkan, et al.
Publicado: (2020) -
Incidence and Risk Factors of Deep Vein Thrombosis in Hospitalized
COVID-19 Patients
por: Yu, Yuan, et al.
Publicado: (2020) -
Characteristics of Acute Pulmonary Embolism in Patients With COVID-19 Associated Pneumonia From the City of Wuhan
por: Chen, Jianpu, et al.
Publicado: (2020)